ESTRO 2024 - Abstract Book

S1442

Clinical - Head & neck

ESTRO 2024

(45%). The correlation between both scores was studied using the Spearman test and the analysis of BIS according to two groups of responses to EORTC SHQ-C22 items: positive answers (very much or quite) or negative answers (never or a little) was studied using the Mann-Whitney test.

Results:

The mean BIS score was 16.63 ± 9.20 with extremes ranging from 10 to 40. The mean EORTC SHQ-C22 score was 60.90 ± 13.61 with extremes ranging from 29 to 77. Patients had negative responses to the items of Importance of sex, libido preservation, fatigue and treatment impact, communication with the doctor, communication with the partner, preservation of sexual life, degree of satisfaction to sexual life and confidence during erection for men in 23 (57.5%), 12 (24%), 12 (24%), 38 (95%), 20 (50%), 17 (42.5%), 17 (42.5%) and 8 (25.8%) respectively. The correlation between both scores was significant (p= 0.017) with inverted variation and weak link (Rho = -0.377). Analysis of the BIS according to the two groups of positive or negative responses was significant only for the degree of patients’ satisfaction with their sexual life (p=0.030).

Conclusion:

Body image and sexual health seem to be interrelated; the alteration in one of them can harm the other. However, the lack of specific scales to assess these two parameters in patients with HNC has made it difficult to demonstrate this link, doubling the need to establish specific scales for this category of patients to better clarify it in the future.

Keywords: body image, sexuality, quality of life

2994

Digital Poster

Neoadjuvant Chemoradiation for Oral Squamous Cell Carcinoma: The Prospective Phase II INVERT Trial

Maximilian Fleischmann 1 , Alexander Kristen 1 , Philipp Thönissen 2 , Ria Winkelmann 3 , Iris Burck 4 , Christian Issing 5 , Markus Diefenhardt 1,6 , Daniel Martin 1,7,8 , Christian Brandts 9 , Andreas Weigert 10 , Franz Rödel 1,6,8 , Sharam Ghanaati 2 , Panagiotis Balermpas 11 , Jens von der Grün 11 , Claus Rödel 1,6,8 1 University of Frankfurt, Department of Radiotherapy and Oncology, Frankfurt am Main, Germany. 2 University of Frankfurt, Department of Oral, Maxillofacial and Facial Plastic Surgery, Frankfurt am Main, Germany. 3 University of Frankfurt, Dr. Senckenberg Institute of Pathology, Frankfurt am Main, Germany. 4 University of Frankfurt, Department of Diagnostic and Interventional Radiology, Frankfurt am Main, Germany. 5 University of Frankfurt, Department of Otorhinolaryngology, Frankfurt am Main, Germany. 6 University of Frankfurt, Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany. 7 German Cancer Research Center (DKFZ), German Cancer Research Center (DKFZ), Heidelberg, Germany. 8 German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Frankfurt am Main, Germany. 9 University of Frankfurt, Department of Medicine, Hematology/Oncology, Frankfurt am Main, Germany. 10 University of Frankfurt, Institute of Biochemistry I, Frankfurt am Main, Germany. 11 University Hospital Zurich, Department of Radiation Oncology, Zürich, Switzerland